SCHEMBL6270844

SCHEMBL6270844

CCNCc1cc(N)ccc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
SLC6A2 P23975 1/20 0.42
PRKCI P41743 1/20 0.39
ACHE P22303 2/20 0.38
CASP1 P29466 2/20 0.35
MAPT P10636 6/20 0.34
ALDH1A1 P00352 5/20 0.34
GAA P10253 4/20 0.34
KDM4E B2RXH2 3/20 0.34
POLB P06746 3/20 0.34
HTT P42858 2/20 0.34
MEN1 O00255 2/20 0.34
USP2 O75604 2/20 0.34
KMT2A Q03164 2/20 0.34
TP53 P04637 1/20 0.34
CASP7 P55210 1/20 0.34
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 3/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6269355 0.85 SLC6A4 (0.44) SLC6A4SLC6A3SLC6A2PRKCIACHE
Hydrochloric Acid SCHEMBL6855463 0.83 SLC6A4 (0.43) SLC6A4SLC6A3SLC6A2PRKCIACHE
SCHEMBL6256708 0.81 CCR5 (0.48) SLC6A4SLC6A3SLC6A2CASP1MAPT
SCHEMBL23254196 0.81 BCHE (0.46) SLC6A4SLC6A3SLC6A2ACHEALDH1A1
SCHEMBL6272594 0.80 HRH4 (0.46) SLC6A4SLC6A3ALDH1A1MEN1KMT2A
SCHEMBL1708812 0.79 MAPT (0.39) SLC6A4SLC6A3SLC6A2PRKCIACHE
Hydrochloric Acid SCHEMBL6685629 0.79 CYP1A2 (0.45) ACHEMAPTALDH1A1POLBMEN1
Hydrochloric Acid SCHEMBL6270325 0.79 CYP1A2 (0.45) ACHEMAPTALDH1A1POLBMEN1
SCHEMBL6269123 0.78 MC4R (0.40) SLC6A4SLC6A3SLC6A2ALDH1A1KDM4E
SCHEMBL18392592 0.77 ADRA2B (0.53) SLC6A4SLC6A3SLC6A2PRKCIACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1116711-B1 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds WELLA AG (DE) 2005-12-14 EP disclosed
US-6800097-B2 FOR DYEING KERATIN FIBERS; HAIR DYES WELLA AKTIENGESELLSCHAFT (DE) 2004-10-05 US disclosed
US-6780998-B2 DEVELOPER-COUPLER SUBSTANCE COMBINATION HAIR DYES WELLA AKTIENGESELLSCHAFT (DE) 2004-08-24 US disclosed
US-20030070241-A1 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) 2003-04-17 US disclosed
US-20020189033-A1 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same WELLA INTERNATIONAL OPERATIONS SWITZERLAND SARL (CH) 2002-12-19 US disclosed
US-6436152-B1 Substituted 2-aminoalky-1,4-diaminobenzene compounds and oxidation dye precursor compositions containing same WELLA AKTIENGESELLSCHAFT (DE) 2002-08-20 US disclosed
EP-1116711-A2 2-aminoalkyl-1,4-diaminobenzene derivatives and dye composition containing these compounds Wella Aktiengesellschaft (DE) 2001-07-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020189033-A1 Substituted 2-aminoalkyl-1,4diaminobenzene compounds and oxidation dye precursor compositions containing same DDT, CYP1B1, ALDH7A1 SLC6A4 2020/4885SLC6A3 1837/4885SLC6A2 2986/4885
US-20030070241-A1 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same DDT, ALDH7A1, DDC SLC6A4 2633/4885SLC6A3 1753/4885SLC6A2 3301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.